NYMC Faculty Publications
Lipids, Blood Pressure and Kidney Update 2014
Author Type(s)
Faculty
DOI
10.1016/j.phrs.2015.03.009
Journal Title
Pharmacological Research
First Page
111
Last Page
125
Document Type
Article
Publication Date
1-1-2015
Department
Medicine
Keywords
Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Hypertension, Hypolipidemic Agents, Kidney Diseases, Lipids, Practice Guidelines as Topic
Disciplines
Medicine and Health Sciences
Abstract
This paper is an effort to review all the most important studies and guidelines in the topics of lipid, blood pressure and kidney published in 2014. Irrespective of advances, the options for improving simultaneous hypercholesterolemia and hypertension management (as well as its complication - chronic kidney disease) remain a problem. Recommending hypolidemic, hypotensive and kidney disease drugs to obtain therapy targets in cardiovascular, diabetic, elderly and kidney disease (=high risk) patients might strengthen risk factor control, improve compliance and the therapy efficacy, and in the consequence reduce the risk of cardiovascular events and mortality rate. That is why the authors have decided to summary and discuss the recent scientific achievements in the field of lipid, blood pressure and kidney.
Recommended Citation
Banach, M., Aronow, W. S., Serban, C., Sahabkar, A., Rysz, J., Voroneanu, L., & Covic, A. (2015). Lipids, Blood Pressure and Kidney Update 2014. Pharmacological Research, 95-96, 111-125. https://doi.org/10.1016/j.phrs.2015.03.009
